Mayan Medicinal Plants Bignonia potosina and Thouinia paucidentata Demonstrate Anti-Infective Properties Against the Priority Antibiotic-Resistant Bacteria Acinetobacter baumannii and Pseudomonas aeruginosa

Gloria María Molina-Salinas,Angel Dzul-Beh,Andrés Humberto Uc-Cachón,Haziel Eleazar Dzib-Baak,Avel Adolfo González-Sánchez,Geovani Antonio Palma-Pech,Carlos Javier Quintal-Novelo
DOI: https://doi.org/10.3390/plants13243498
2024-12-15
Plants
Abstract:(1) Background: Carbapenem-resistant Acinetobacter baumannii (CBRAB) and Pseudomonas aeruginosa (CBRPA) are critical and high-priority pathogens that require new therapeutic developments. Medicinal plants are valuable pharmaceutical resources. This study explored the anti-infective properties of Mayan plants, Bignonia potosina, and Thouinia paucidentata. (2) Methods: Plant parts were extracted using n-hexane, and their ability to inhibit bacterial growth and counteract resistance mechanisms and virulence factors in CBRAB and CBRPA was assessed. GC-MS analysis of the composition of the non-polar extracts and chemometric techniques correlated the phytoconstituents with anti-infective properties. (3) Results: Bignonia potosina liana and flower extracts exhibited potent antibacterial activity against A. baumannii strains (MIC 15.7 to 250 μg/mL) and moderate activity against P. aeruginosa strains (MIC 250 to 1000 μg/mL). Thouinia paucidentata leaf extract at 1000 μg/mL reduced imipenem MIC by 2048-fold for CBRAB, and B. potosina flower extract significantly inhibited A. baumannii catalase activity (at 62.5 μg/mL) and reduced P. aeruginosa pyocyanin production (at 1000 μg/mL). Chemometric analysis identified fatty acids, fatty acid amides, terpenes, and higher alkanes as contributors to their anti-infective properties. (4) Conclusions: This study highlights the potential of medicinal plants in the development of novel anti-infective therapies against CBRAB and CBRPA with various targets.
plant sciences
What problem does this paper attempt to address?